Clinical Trials Browser

Phase 1/2 × camrelizumab × Other solid neoplasm × Clear all

NCT05699811 2023-04-28

IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT03171220 2017-06-06

NRT-01

Phase 1/2 Unknown

Other solid neoplasm

Advanced Malignant Solid Tumor